Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2020-A01290-39 | Other Identifier | DGS, Ministry of Health |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Cancer and its treatments can be factors that alter the quality of life of patients. The induced alteration of the quality of life can influence compliance and impact survival. Considering the after-effects of the treatment, carrying out such a survey will provide for the first time precise information on the main determinants of the quality of life as well as on the care pathway of patients with invasive breast cancer in the Martinique region.
Breast cancer is the second most common cancer in the West Indies and the leading cancer in women. With 215 new cases in Guadeloupe, 204 in Martinique and 56 in French Guiana each year, it accounts for 37%, 33% and 26% of incident cancer cases in women respectively, but also affects men. Its incidence, lower than in France, is increasing over the period 2008-2014. The diagnostic and therapeutic management of cancer can have an impact on the quality of life of patients, taking into account the adverse effects occurring during and after treatment, both in the short and long term. The European Organisation for Research and Treatment of Cancer (EORTC) has developed a series of questionnaires to assess the quality of life of cancer patients, including a general questionnaire (QLQ-C30) and specific modules for breast cancer (EORTC BREAST (EORTC QLQ-BR23)) with the objective of improving professional practices.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Quality of life questionnaires | Other | Patients' quality of life will be assessed with self-reported items through both the EORTC-QLQ-C30 and EORTC-QLQ-BR23 modules. |
| Measure | Description | Time Frame |
|---|---|---|
| Assessment of global disorders in patients with breast cancer | Quality of life of patients with invasive breast cancer in Martinique assessed by QLQ-C30 | 12 months after diagnosis |
| Assessment of disorders specific to breast cancer patients Assessment of disorders specific to breast cancer patients | Quality of life of patients with invasive breast cancer in Martinique assessed by QLQ-BR23 | 12 months after diagnosis |
| Assessment of global disorders in patients with breast cancer | Quality of life of patients with invasive breast cancer in Martinique assessed by QLQ-C30 | 36 months after diagnosis |
| Assessment of disorders specific to breast cancer patients | Quality of life of patients with invasive breast cancer in Martinique assessed by QLQ-BR23 | 36 months after diagnosis |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients with breast cancer followed at the Martinique University Hospital
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Clarisse JOACHIM-CONTARET | CHU Martinique | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CHU Martinique | Fort-de-France | 97261 | Martinique |
Not provided
| ID | Term |
|---|---|
| D001943 | Breast Neoplasms |
| ID | Term |
|---|---|
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D001941 | Breast Diseases |
| D012871 | Skin Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| D017437 |
| Skin and Connective Tissue Diseases |